G104S (p.Gly104Ser) variant of KRT9 (Keratin, type I cytoskeletal 9)

G104S (p.Gly104Ser) in KRT9 (Keratin, type I cytoskeletal 9) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

G104S (p.Gly104Ser) variant details